Does body mass index predict response to intravenous ketamine treatment in adults with major depressive and bipolar disorder? Results from the Canadian Rapid Treatment Center of Excellence.

Orly Lipsitz Roger S McIntyreNelson B RodriguesYena LeeHartej GillMehala SubramaniapillaiKevin KratiukFlora NasriRodrigo B MansurJoshua D Rosenblat

Published in: CNS spectrums (2020)

The findings are limited by the observational, open-label design of this retrospective analysis. Pretreatment BMI did not predict response to IV ketamine, which was effective regardless of BMI.

Keyphrases

body mass index
bipolar disorder
open label
weight gain
pain management
major depressive disorder
clinical trial
physical activity
radiation therapy
cross sectional
high dose
low dose
replacement therapy
quantum dots
smoking cessation